Bradykinin-induced preconditioning in patients undergoing coronary angioplasty
- 2 September 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 34 (3) , 639-650
- https://doi.org/10.1016/s0735-1097(99)00297-1
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Medical and Cellular Implications of Stunning, Hibernation, and PreconditioningCirculation, 1998
- Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activationJournal of the American College of Cardiology, 1996
- Role of Bradykinin in Protection of Ischemic Preconditioning in Rabbit HeartsCirculation Research, 1995
- Preconditioning During IschemiaCardiology in Review, 1995
- Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptorsBritish Journal of Pharmacology, 1994
- Does ischemic preconditioning occur in patients?Journal of the American College of Cardiology, 1994
- Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitationTrends in Pharmacological Sciences, 1994
- Prevention by an inhibitor of the l‐arginine‐nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogsBritish Journal of Pharmacology, 1993
- Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogsBritish Journal of Pharmacology, 1991
- Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.Circulation, 1986